Biologically active peptides comprising...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S329000

Reexamination Certificate

active

07396817

ABSTRACT:
The peptide Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) is disclosed with its use as a pharmaceutical composition in reducing symptoms of viral disease and stimulating properties of immune system in a subject. A method is also disclosed for making a pharmaceutical composition comprising providing an Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) peptide and mixing said peptide with a pharmaceutical acceptable carrier.

REFERENCES:
patent: WO 0175067 (2001-11-01), None
Bouchonnet et al. Fragmentations of Dipeptides in Plasma Desorption Mass Spectrometry . . . Biological Mass Spectrometry. 1992, vol. 21, pp. 576-584.
Vassilev Milen et al. “Effect of low molecular weight glycoproteins in chronic hepatitis B” Hepato-Gastroenterology, vol. 43, No. 10, 1996, p. 882-886.
Database Geneseq, Feb. 13, 2002 retrieved from EBI, accession no. ABG03266, SEQ ID No. 33625 SEQ ID No. 33625 of WO0175067.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Biologically active peptides comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically active peptides comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active peptides comprising... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3964739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.